I’ve been a prisoner on the Moroccan slaveship since Covidiocracy started, under the command of King Pfizer I the Destroyer of Morocco and the rule of other people we’ll discuss later. I can’t go far without being molested by the government so I can’t report as a witness to everything, but I still can provide sources and insights you won’t find many places, and believe me, this is a really interesting and telling story.
Morocco is the most jabbed country in Africa, about 3/4 of the population had at least one shot, and I was growing depressed and desperate with these stats and the deafening silence around, as I f-ing love these people and I was hurting being a direct witness to their silent suicide.
I couldn’t understand how can they be so alive inside, individually, but dead as a community.
It was peace because the regular folk here have simple sane natural mentalities and, more so than in many ‘free-minded’ Western societies, they respect each other’s options and allow their neighbor to follow and meet his destiny. Within the framework of Quran. of course, but parallel with the legal framework and propaganda. So whatever was going on was creating big economic problems, but not social tensions and division.
This could’ve been almost a successful vaccination rollout, definitely the best in the region, on the background of an economic and health calamity. But then the rulers of the land decided to ruin their own only achievements lately and made the mistake to push the pedal to the metal with these green-passes, because they’re 200% aboard the Great Reset and all that Davos transhumanist lunacy, especially the king, as vaccines are just the gateway to digital ID’s. And this is the part where other fine gentlemen come in. More on that coming up too.
So when the ‘green’ slave passes hit, what everyone suspected became clear: the whole circus is not about health, their suffering so far was not about mitigating a crisis, quite the opposite.
And now you have what you don’t find everywhere: a more cohesive and clear-minded society, with enough protest experience, loudly standing up to the bullshit, and some frowning bystanders who are completely clueless or confused. No millennial CDC Karens here, that NPC model is not even on the market yet.
Soon, I will reveal how we got here, decades of history, I’ve only scratched the surface before, time to crack it open. Until then…
To be continued? Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Moroccan budget is largely dependent on investors to subsidise its large deficit. Two of its best partners are a couple of banks not quite known in the Western world. Until now. Bill Gates has his hands deeply in both of them. And this sting is now hurting Morocco and costing it $3Billion a month. I’m just scratching a surface here, but you can peep in now. Something like this might be happening in your country too.
Completed in my 9th day of hunger strike, under an insane and scientifically unjustified lockdown in Morocco. It was important to publish it now, while I still can, and if my destiny is generous, I will perfect it. The point is made anyway.
UPDATE: On December 22, 2020 this investigative endeavor found its closure and many of the questions I raised found an answer. I added the newest evelopments at the end, but when all this was written I didn’t know what the punchline will be, I only had hunches, so I left the end open.
The African Development Bank (ADB / AfDB)
Veteran banking partner of Morocco, The African Development Bank Group or Banque Africaine de Développement is a multilateral development finance institution. The AfDB was founded in 1964 and comprises three entities: The African Development Bank, the African Development Fund and the Nigeria Trust Fund. – Wikipedia CEO: Akinwumi Adesina (Sep 1, 2015–) Headquarters: Abidjan, Côte d’Ivoire Founded: September 10, 1964 Leader: Akinwumi Adesina Subsidiaries: African Development Fund, Nigeria Trust Fund, and more
“In this first academic study of the ADB, Karen Mingst argues that the bank is a political institution, not the functional, economically neutral organization originally envisioned. Using bank archives and extensive interviews with ADB personnel, contractors, the economic development community, and national government officials, Mingst analyzes the changing political relationships in the ADB in three arenas: intraorganizational politics with effects on the secretariat and on policy issues, political relations with other development organizations, and hegemonic politics among politically and economically powerful state members.”
However, I suspect some big voters are not on that list, are not even countries, but are richer than some countries. Riddle me this…
Did you know? Bill Gates’ fortune in 2017 was roughly equal to Morocco’s GDP.
The Islamic Development Bank (IsDB)
Not a new actor on the local market either, IsDB is a multinational based in Saudi Arabia and it describes itself as “a multilateral development bank (MDB), working to improve the lives of those we serve by promoting social and economic development in Member countries and Muslim communities worldwide, delivering impact at scale.
We provide the infrastructure to enable people to lead better lives and achieve their full potential.
We bring together 57 member countries across four continents – touching the lives of 1 in 5 of the world’s population.
We are one of the world’s most active MDBs, and global leaders in Islamic Finance, with an AAA rating, and operating assets of more than USD 16 billion and subscribed capital of USD 70 billion.
We are a truly global institution, headquartered in Jeddah, Saudi Arabia, with major hubs in Morocco, Malaysia, Kazakhstan and Senegal, and gateway offices in Egypt, Turkey, Indonesia, Bangladesh and Nigeria.
We foster collaboration between our members nations in a uniquely non-political environment, as we focus on the betterment of humanity.
IsDB seems to have earned contract after cotract with the government, too many to mention, they’re seriously competing AfDB. Competing or completing…
Until 2017, Morocco has received a total of USD 7.6 billion from the Islamic Development Bank (IDB) group since its establishment in 1974, according to Bandar Al-Hajjar, president of the IDB.
You know who else is an even more “fervent” collaborator for IsDB? I mean so close they should share offices?
Yeah, Bill Gates, of course.
THE TIMELINE (incomplete)
June 4, 2009
World Bank, the African Development Bank, Gates Foundation, and DEG set up “Health in Africa Fund” under Chinese management
From the official press release: “IFC, a member of the World Bank Group, the African Development Bank, the Bill & Melinda Gates Foundation, and the German development finance institution DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH announced June 4, 2009 that they have created a new private equity fund that will invest in Africa’s health sector.
The Health in Africa Fund, managed by Aureos Capital, will invest in small- and medium-sized companies in sub-Saharan Africa, such as health clinics and diagnostic centers, with the goal of helping low-income Africans gain access to affordable, high-quality health services. The fund will be measured not only by fiscal performance but also by its ability to cultivate businesses serving the poor.
The Health in Africa Fund is part of IFC’s Health in Africa Initiative under which IFC intends to mobilize up to $1 billion in investment and advisory services over five years, following publication of its 2007 Business of Health in Africa report, which focuses on how to improve people’s lives by partnering with the private sector. Besides the equity vehicle, IFC is improving access to long-term financing for smaller companies involved in health care through local financial intermediaries. Together with the World Bank and other partners, IFC is working with governments to help them better harness the private sector to achieve national health goals and is producing the first biennial report on Africa’s health care investment climate.
IFC, a member of the World Bank Group creates opportunity for people to escape poverty and improve their lives. We foster sustainable economic growth in developing countries by supporting private sector development, mobilizing private capital, and providing advisory and risk mitigation services to businesses and governments. Our new investments totaled $16.2 billion in fiscal 2008, a 34 percent increase over the previous year.
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.
DEG, a member of KfW Bankengruppe (KfW banking group), is one of the largest European development finance institutions. DEG invests in profitable projects that contribute to sustainable development in all sectors of the economy, from agribusiness to infrastructure and manufacturing to services. DEG’s aim is to establish and expand private enterprise structures in developing and emerging countries and thus create the basis for sustainable economic growth and a lasting improvement in the living conditions of local populations. In 2008 DEG invested around 1.22 billion euros which is about 1.6 per cent more than the previous year.
About Aureos Capital Limited
Aureos Capital Ltd. is a private equity fund management company which specializes in providing expansion and buy-out capital to unlisted small to mid-cap businesses across Asia, Africa, and Latin America. Since its establishment in 2001, Aureos has increased its funds under management to over $1 billion and established 15 regional private equity funds. It has extended its geographical footprint to over 50 emerging markets covering Africa, Asia, and Latin America. Investors in Aureos funds include institutional investors, bilateral and multilateral development finance institutions, pension funds, sovereign wealth funds, fund of funds, family offices and foundations, and high net worth individuals.”
The phosphate industry gets some love. But who’s the phosphate industry?
Morocco’s state-run phosphate, OCP Group, (Office Cherifien des Phosphates) has received a $150 million loan from IsDB to improve its infrastructure and repair facilities at Jorf Lasfar, a deepwater commercial port located on Morocco’s Atlantic coast. Phosphates are “Morocco’s white gold”, according to Bloomberg, the main natural resource for export in Morocco. “King Mohammed VI owns more than half the world’s phosphate reserves. James Prokopanko, chief executive officer of Plymouth (Minn.)-based fertilizer giant Mosaic (MOS), has called Morocco the Saudi Arabia of phosphate, with all that implies about the King’s power to influence prices and economies.”
If you want to harvest some billions, you need to seed some millions
According to Morocco World News, in 2014, the IDB amounted to $0.18 billion to Morocco in order to carry out drinking water supply projects in the regions of Agadir and Chtouka Ait Baha, as well as the olive sector for small farmers.
In the same year, oil refiner Samir received a loan of $240 million to finance crude oil imports. Which allegedly refines oil from a company that belongs to the minister of Agriculture, coincidentally Morocco’s richest man, besides the King. By the way, agriculture loves oil and phosphates.
The IDB has also embarked on signing agreement with partners to invest in Morocco. In 2014, it signed a joint agreement with Kuwait Investment Authority (KIA) to invest in Moroccan private sectors.
And so forth
February 25, 2015
Moroccan Government employs AfDB to diagnose economy
“Working in close collaboration, the Kingdom of Morocco, African Development Bank (AfDB) and the United States Millennium Challenge Corporation (MCC), have conducted an exhaustive study on constraints and strengths impeding the country’s determination to promote a strong, sustained and shared growth. The study, entitled Morocco’s Economic Growth Analysis: Identifying Constraints to Broad-Based Growth* is derived from in-depth data-driven analysis supported by consultations with all government ministries, private sector, academia and civil society in Morocco. Its objective is to clearly identify constraints to private investment in Morocco and identity priority issues to be addressed in order to grow a strong, dynamic economy.” This report was officially launched on February 25, 2015 at Rabat Conference Centre. AfDB president Donald Kaberuka participated in the event alongside the Head of the Government of Morocco, Abdelilah Benkirane, and the Ambassador of the United States of America to Morocco, Dwight Bush (a banker as well), among others.
“The 2015 Growth Diagnostic conducted by Morocco, the African Development Bank and the Millennium Challenge Corporation (MCC) identified education and certain aspects of the legal framework (taxation, the justice system and land ownership) as major constraints to the development of small and medium sized enterprises (SMEs). The size of the informal economy has also been regularly blamed. The new “self-entrepreneur” status created in 2015 and the gradual extension of social benefits to the self employed should allow some of those operating in the informal economy to move into the formal sector.”, reports African Economic Outlook
March 11, 2015
AfDB Board approves The Bill and Melinda Gates Foundation Trust Fund
The Board of Directors of the African Development Bank Group on Wednesday, March 11, 2015 in Abidjan approved the establishment of the Bill and Melinda Gates Trust Fund to be hosted by the Bank.
The Fund’s US $2.4 million initial contribution will support forward-thinking on the issue of concessional finance in development by an African Development Fund (ADF) Policy Lab. It would also support other future Bank activities.
It is the first bilateral fund with a non-sovereign entity, and the first bilateral fund with the Foundation aimed to provide structure to the long-standing collaboration with the Bank and scale up areas of intervention.
The Bank currently manages about 39 trust funds most of which are depleted.
There was overwhelming support for the collaboration, which fits squarely with the Bank’s Ten Year Strategy. The Strategy looks to engage in strategic partnerships to disseminate knowledge and lead new policy initiatives.
The ADF Policy Lab will complement the Mid-Term Review of the ADF, which is the pool of concessional resources dedicated to less endowed Regional Member Countries.
Bill Gates joins Monsanto in an attempt to take over Africa’s food with GMO’s
If you think Gates has a passion or obsession for medicine, I’m afraid that’s just one of his many tools for control and power grabs. An even more powerful tools in this kit is food, so of course Billy Boi has been long involved in this too. The other mega-company that shared his views almost in verbatim copy is the infamous Monsanto. So no one should be surprised that The Bill & Melinda Gates Foundation met Monsanto to discuss business behind closed doors in London, in March 2015. Which event even sparked street protests at the time, the Gates Foundation getting picketed in several locations.
Bill Gates visits Morocco and unveils collaboration with IsDA, becomes news sensation
Gates’ Foundation representatives attended a meeting with the regional head of the Tangier-Tetouan-Al Hoceima region and representatives from the Islamic Development Bank to discuss Bill Gates’ first visit Morocco in the coming months.
Bill Gates’ trip to Morocco comes after a two-month long effort made by Ilya El Omari, head of the Tangier-Tetouan-Al Hoceima and President of the Party of Authenticity and Modernity (PAM) to convince Microsoft’s founder to visit the North African country. The information was not denied by the PAM.
It seems however, that news, which went viral and was published by most news outlets, including Morocco World News, is not accurate.
According to an email sent by the Bill and Melinda Gates Foundation to Moroccan journalist Anas Bendrif, the “media reports about funding of projects in Morocco are not correct.”
While the Foundation’s did not deny the visit reported by Moroccan media, it pointed out, however, that that no investment is being planned yet in Morocco, adding that any decision in this regard is made by the Islamic Development Bank.
“The Bill and Melinda Gates works with partner organization around the world, including the Islamic Development Bank, to explore new ways of cooperation on initiatives that will help lift the poor out poverty and provide then with brighter future. This includes on-the-ground visits to various communities and regions to learn more about their greatest needs, which may benefit from our joint initiative: the Lives and Livelihoods Fund,” Cecilie, the foundation’s representative said in the email.
“We have no confirmed any projects at his time in Morocco, but we continue to explore potential opportunities wen we will announce those once they materialize.” – Source
Bill Gates Foundation grant for African Development Bank
November 16, 2018
The African Development Bank announces a new initiative to promote innovation and citywide inclusive sanitation services for sub-Saharan Africa’s urban inhabitants. The Bank’s Africa Urban Sanitation Investment Fund Program, with support from the Bill & Melinda Gates Foundation, is funding the initiative designed to focus on the poor.
The Gates Foundation, in partnership with the Government of the People’s Republic of China, showcased the new initiative at the Reinvented Toilet Expo in Beijing from 6-8 November 2018. The Reinvented Toilet Expo brought together private and public-sector leaders pushing for faster adoption of innovative, pro-poor sanitation technologies in the world’s developing regions.
“Support from the Bill & Melinda Gates Foundation enhances the Fund’s ability to address sanitation in urban areas for greater outcomes, including in health, nutrition, environment, and employment,” bank officials said.
“The Bill & Melinda Gates Trust Fund funded a study on how to improve connectivity between payment systems and create greater financial inclusion for West Africans, as well as an investment to the Africa Digital Inclusion Fund. Originally $2.4 million, the trust fund now tops $17.9 million due to additional funding by the Gates Foundation.” reports Devex
Meet Rodrigo Salvado
“Before joining the Bill & Melinda Gates Foundation, Rodrigo worked for the African Development Bank Group where he was in charge of the Performance Based Allocation System of the African Development Fund”. So AfDB is so bad-ass it has people in Gates’ Foundation?!
Salvado holds a Master in Public Administration in International Development from Harvard Kennedy School of Government, a Master in Economics from the Centro de Estudios Monetarios y Financieros in Madrid, and a Bachelor of Science in Economics from the Universidad Torcuato Di Tella in Argentina.
26 March 2018
AfDB reveals it’s also in cahoots with the Rockefellers and Soros
ABIDJAN — Purse-string tightening by traditional international development donors in recent years has prompted the African Development Bank to cast a wider net in seeking aid funding. One of the areas that has seen success, the bank told Devex, is securing financing from philanthropic organizations.
In February, the Rockefeller Trust Fund provided an initial $3 million to support two of the AfDB’s “High 5” development priorities. The financing will go toward the Leadership for Agriculture Platform — in alignment with the “Feed Africa” pillar — and a youth coding skills training program in connection with the “Improving the Quality of Life for People in Africa” pillar.
The department is currently developing relationships with other socially responsible NGOs including the Ford Foundation and the Open Society Foundations (George Sorors). But Dabady added that the AfDB needs to better communicate the tangible results produced from funding in order to sustain and form partnerships with private foundations.
May 17, 2018
African Development Bank drops 200 million Eu in Morocco’s Agriculture
Rabat – African Development Bank (BAD) has outlined EU 200 million loan dedicated to finance the program of support for the inclusive and sustainable development of agricultural sectors in Morocco.
The new operation aims to support job creation in rural areas through the inclusive development of agricultural value chains, the African bank said in a statement.
The country manager of the BAD in Morocco, Leila Farah Mokaddem, highlighted how the project is projected to boost Morocco’s exports revenues to MAD 45 million by 2030 and save 990 million cubic meters of water. By 2020, it aims to mobilize MAD 4 billion of private investment in the agricultural sector to create thousands of jobs for young people and women in rural areas.
While Africa still doesn’t have clean water, Gates and AfDB bestow it with “digital financial services”. For the people
In 2019, the Bank partnered with the Bill & Melinda Gates Foundation, the Government of Luxembourg and Agence Française de Développement to set up the Africa Digital Financial Inclusion Facility (ADFI). ADFI is a blended finance vehicle that aims to scale up digital financial services in Africa to accelerate financial inclusion and ensure that digital financial systems include and empower everyone, especially women.
January 22, 2019
Moroccan Government sign a new agreement for Agenda 2030 implementation
Rabat – “The Moroccan high commissioner for planning (HCP), Ahmed Lahlimi Alami, the deputy resident representative at the UN Development Assistance Framework, Martine Therer, and 10 UN agencies in Morocco signed an agreement in the framework of the UN 2030 Agenda for Sustainable Development Goals (SDGs)on Tuesday.
During a ceremony at the HCP headquarters in Rabat, the two officials discussed the agreement which is also part of the UNDAF 2017-2021 framework.
The agreement will facilitate the tracking of and reporting of SGD progress in the country to better “inform the policymaker and the public on the progress” of sustainable development in their country.
The agreement is valid for three years and will focus on the following objectives: “The use of performance and statistical data of the Sustainable Development Goals program, the preparation of periodic reports concerning the progress of these goals on national and regional levels, with the help of consultation mechanisms put by the program and through south-south cooperation networks.”
Morocco has made advances in a significant number of SDGs, according to a report by the Economic Commission for Africa released in November.
The report, however, entailed that youth employment, climate change, food security, and industrial transition were some of the complex challenges that Morocco still needs to address.”
Apr 3-6, 2019
Islamic Development Bank holds annual meeting in Morocco, discusses Agenda 2030
The event convenes the bank’s Board of Governors each year to discuss institutional and development issues, pulling in experts and development specialists from around the globe. 2018’s event took place in Tunis.
This year, the meeting’s slogan is “Transformation in a changing world,” a reference to the new development strategy the bank’s president Bandar Hajjar will unveil. The new strategy dovetails with the UN’s Sustainable Development Goals (SDGs), according to IsDB. “Morocco is one of IsDB’s most important partners. The institution has worked extensively with the kingdom, most recently launching a multimillion dollar fund for science and technology in Morocco.” reports local media.
In February, lauding Morocco’s use of private-public partnerships, one of the new “core pillars” of the IsDB, Hajjar called the North African country a “model and a reference” for its other member countries, writes MWN. Allow me to translate: Private-public partnerships is code for “siphoning public funds”. New “core pillars” of the IsDB is code for “Morocco’s budget has become our main provider now”.
Who else loves Agenda 2030 and works to implement it? If you think Bill Gates, you’re not wrong, but if you think Morocco’s government you’re also right.
But I guess no one loves Agenda 2030 deeper than Israel.
And then Covid-19 hit
May 18, 2020
Economy Minister: Lockdown Costs Morocco MAD 0.1 Billion a Day
Rabat – Morocco’s Minister of Economy, Finance, and Administration Reform, Mohamed Benchaaboun, stated that the country loses up to MAD 1 billion ($100 million) during each day under lockdown, noting it is expected that the two months of quarantine will cause the national economy to lose 6 points of GDP growth for 2020.
“The loss would have been greater if financial support had not been provided by the COVID-19 pandemic management fund, which was created on royal instructions,” explained Benchaaboun in the weekly session dedicated to parliamentary questions on Tuesday.
On the fiscal level, he added that “the economic recession is expected to cause a shortfall in Morocco’s treasury revenues of approximately MAD 500 million per day during the quarantine period.”
Benchaaboun went on to say that Morocco has been largely affected by the repercussions of the health crisis at the economic and financial levels, as shown by a set of economic indicators.
Meanwhile, the small-time local bankers get pushed around by Covid too
Rabat – International ratings agency Fitch Ratings has downgraded three Moroccan banks’ outlooks from “stable” to “negative.”
The study included Attijariwafa Bank (AWB), BMCE Bank of Africa (BOA) and Credit Immobilier et Hotelier (CIH).
The evaluations follow Fitch Ratings’ latest revision of Morocco’s outlook to “negative” from “stable” on April 28, due to the coronavirus crisis.
Fitch Ratings indicated that AWB and BOA are classified as domestic systemically important banks (DSIB) in Morocco, and believes that the government would have a high propensity to support them if needed.
However, the ratings agency classifies the overall probability of Moroccan support as moderate, given the negative repercussions of the pandemic on Morocco’s economy.
Despite Morocco’s proactive response to address the negative shocks of the pandemic, Fitch expects the Moroccan economy to contract 4.5% in 2020. The agency also predicts general government debt to rise to 58% of GDP in 2020 from 52.5% in 2019.
If the projection proves true, it will interrupt 22 successive years of growth – Morocco World News
May 20, 2020
Heavily impacted by the lockdown, a significant number of Moroccan companies have declared bankruptcy
Rabat – Morocco’s Minister of Economy and Finance, Mohamed Benchaaboun, has called on companies to resume their activities after the end of Ramadan, Eid Al Fitr, to revive the lockdown-stressed national economy.
The economic resumption concerns companies that have not been prohibited from continuing their activities, and the proposed measure does not include companies that opted for remote work.
Companies excluded from the call are those active in catering services, hotels, and places of gathering.
Benchaaboun made the request during a Parliament session dedicated to the government’s economic and financial measures to mitigate the repercussions of the COVID-19 crisis on Tuesday, May 19.
Seizing the opportunity, Benchaaboun shared with parliamentarians an update on expenses of the Special Fund for the Management and Response to COVID-19. The minister also highlighted measures the government implemented to support companies, employees, and impacted citizens.
He stated that the fund’s revenues reached MAD 32.7 billion ($3.27 billion) as of Monday, May 18. He added that more than MAD 2.2 billion ($220 million) was allocated to upgrade the health sector while a further MAD 11.5 billion ($1.15 billion) was dedicated to the Economic Watch Committee’s (CVE) measures in favor of impacted businesses and employees.
May 27, 2020
COVID-19: African Development Bank Allocates €264 Million to Morocco
If you had enough influence over a cuntry’s rulers to persuade them to implement some suicidal measures, just so you can appear as saviour later, would you do it? Historically speaking, banksters are usually quite inclined towards such opperations, not t mention Gates. But I digress, check the latest news:
Rabat – The African Development Bank (AfDB) approved today In Abidjan, Cote d’Ivoire the financing of €264 million for Morocco, as part of its COVID-19 response support program (PARC-19).
“With rapid deployment of resources, PARC-19 contributes to bolster the Kingdom’s response efforts to the health, economic and social crisis triggered by the COVID-19 epidemic,” the AfDB said in a press release.
“Faced with this unprecedented situation, we are doing everything in our power to support Morocco to curb the spread of the virus and mitigate its economic and social repercussions,” said AfDB Director General for North Africa, Mohamed El Azizi.
AfDB indicates that protecting the population requires the primary objective of stopping the spread of the COVID-19 virus. The first step also includes improving the effectiveness of the authorities’ response, as well as increasing the number of virological tests.
“The second objective of this operation is intended to help preserve the purchasing power of Moroccans. In this perspective, the program will support public financial support measures, which benefit employees in the formal and informal sectors during the lockdown period,” said the AfDB.
“It will also reinforce [the] government’s efforts to provide support to 4.3 million households in the informal sector as well as 800,000 employees affiliated to the National Social Security Fund (CNSS),” the Bank added.
“Faced with this unprecedented situation, we are doing everything in our power to support Morocco to curb the spread of the virus and mitigate its economic and social repercussions.”
II.ECONOMIC ANDSOCIAL IMPACT OF COVID-19AND GOVERNANCE
“2.1.Recent Developments:Alongside South Africa, Egypt and Algeria, Morocco is among the African countries with the highest COVID-19 cases. The first case was detected on 2 March 2020 in Casablanca, before spreading to all other regions in the country. On 4May2020, Morocco reported 5,053confirmed COVID-19cases, 179 deaths and 1,653 cured cases. With 1,306 confirmed cases, the Casablanca-Settat region is the most affected region, followed by Marrakech-Safi (1,076 cases), Fès-Meknès (662 cases) and Daraa-Tafilalet (548 cases) (Technical Annex4& 5). At the onset of the COVID-19pandemic, the Moroccan authorities declared a state of emergency, adopted confinement measures, including isolation, suspended all international passenger flights, prohibited public gatherings and closed all mosques,schools, universities, eateries and cafés. Similarly, they limited urban/inter-urban land transport and downsized Government and corporate staff. Compulsory confinement, which started on 20 March 2020 and was later extended to 20 May 2020 (and then to 10th of June – writer-s note), has had a significant adverse impact on the national economy.Donors mobilised to support Morocco address the crisis. Under the Precautionary and Liquidity Line (PLL 2018-2020)agreement concluded with the International Monetary Fund (IMF), Morocco withdrew all resources under this line, equivalent to USD 3billion.For its part, the World Bank disbursed a loan of USD 275 million. 2.2.Economic Situation: Like its key trading partners, Morocco’s economy was hard hit by the crisis caused by COVID-19. The tourism sector has lost an estimated MAD 34.1 billion in turnover in 2020, with nearly 6 million fewer tourists,according to the Moroccan Tourism Confederation(CMT). In the automobile sector,the crisis affected the 250 equipment manufacturers operating in the country, leading to a significant drop in Morocco’s balance of trade. The automobile sector accounted for 27% of total exports in 2019, making itthe leading export sector. In the long run, this might impact the 180,000 jobs in the industry. The textile/dress-making sector is also affected by disruptions in supplies, especially from China and falling foreign demand particularly in the European Union. The textile sector, which employs over 160,000 individuals in 1,200 firms, is threatened.With the double shock of drought and COVID-19, the real GDP growth rate will continue to decelerate in 2020. According to AfDB forecasts(Table 1), it will range from -4.6% to -3.3% in 2020, before rising to between 4.1% and 4.3% in 2021, based on worst-case and best-case scenarios. Various structural and contextual factors will contribute these scenarios. The economy will also suffer from the global recession, particularly in its four key economic partners (Spain, France, Italy and Germany) who make up 76% of its external trade”
The most painful reality here is that most, if not all of this is as legal as obvious. You can watch the money flow, witness the suffering of the people, get enraged, but if the law is your moral compass, nothing happened, move on.
And if anyone ever gets arrested, it’s…
May 30, 2020
Test acquisitions are a scandal in Morocco, as everywhere else
Morocco’s Ministry of Health rebutted on May 30 reports claiming a single company with two government contracts worth MAD 400 million ($41 million) is responsible for the procurement of COVID-19 rapid diagnostic tests.
The ministry said it signed a contract for two million rapid diagnostic tests worth MAD 212 million ($21.7 million) that did not entirely cover Morocco’s needs, according to the press release.
The agreement was in accordance with health emergency laws and in full compliance with the principle of competitive contracting, the health ministry explained.
The statement added that the ministry consulted “world-leading” companies in the field to ensure technical and financial evaluation of the offers.
The acquired tests are technically efficient and compatible with national laboratories’ equipment, rendering the purchase and cost of new screening equipment unnecessary, the statement continued.
The Ministry of Health said it benchmarked Morocco’s contract to those of other countries, with the statement explaining, “It is the same price paid by several European and Asian countries for the acquisition of quantities ranging from 6 to 10 million tests.”
The ministry affirmed that it “ensures exemplary application of all legal provisions in order to properly manage the resources placed at its disposal.”
The news comes amid Morocco’s efforts to curtail the spread of misinformation during the COVID-19 crisis.
In March, the Director of Epidemiology at the Ministry of Health, Mohamed Lyoubi, had to deny reports that Morocco purchased 100,000 COVID-19 test kits from a South Korean manufacturer. Basically accusing South Korean media and manufacturers of spreading fake news.
“Since the start of the outbreak in the country, Moroccan laboratories have conducted more than 200,000 tests on suspected carriers, of which 197,805 came back negative”, officials claim.
What Moroccan Government and most world governments have never done since the beginning of the crisis: 1. A risks & costs assessment of their Covid policies, prior to enactment 2. A side-effects assessment of of their Covid policies, post enactment 3. Transparent acquisitions
What did they all do?
Control of media narrative, repression of unaligned speech.
Morocco arrested an old woman for spreading panic by saying there’s no reason to panic. Among other dissenters. And this is the logic of all restrictive Covid-19 policies
Mi Naima literally said in a censored video “don’t be alarmed by the government and media, Coronavirus is a farce”. “Fake news is the first cause of panic among citizens,” said Prime Minister Saad Eddine El-Otmai, in a press conference after Mi Naima’s arrest, comparing the spread of misinformation with the contagion of the disease.
Other people were arrested for opposing strict measures against public gathering, urging people to ignore them, or saying a lockdown had been implemented when it had not.
On the same day, the government approved a draft law governing the use of social media, aiming to deter fake news and cyber crimes undermining public order and the economy.
Rights groups have criticised Morocco for what they see as an increasing crackdown on free speech over the past year, including prison terms for people who have expressed dissent on social media, reports Reuters
Guess which is the only Moroccan business unaffected by Covid
If you paid attention, you guessed right: It’s the Royal phosphate business. QED.
“With the exception of Morocco’s stable phosphates sales, the country’s major export sectors have suffered from the fall in world demand, the breakdown of supply chains, and the disruption of several activities in Morocco, all consequences of the global COVID-19 pandemic.
Morocco’s automobile exports fell by 39% at the end of April, textiles by 28%, aeronautics by 34%, and foodstuffs by 7%.
The losses range from MAD 1.8 billion to MAD 11 billion ($184 million to $1.1 billion).” – reports Morocco World News.
To be continued?
Probably so. I leave you with a mystery: How come Moroccan government approved a famous international Israeli spy and child trafficker like Epstein to land his jet (aka “Lolita Express”) on their airports? Official flight registries and press reports show that it happened at least twice. Seeing that Gates and Epstein were partners, did they use Morocco as a secret meeting ground?
We know for sure Morocco was a generous host to other usurpers:
FOLLOW UPS It has all come together, finally:
To be continued? Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Written while prisoner in Moncef Slaoui’s home-town, Agadir, Morocco
In 2013, the Chinese authorities branded the international pharma giant GSK a “criminal godfather”, accusing it of running a £320m slush fund to bribe doctors and hospital officials with cash payments and visits to prostitutes. – The Guardian American public couldn’t care much, but those events built up to Moncef Slaoui‘s nomination as Trump’s “vaccine czar”
If corruption was a company, it would be GlaxoSmithKline (GSK) with “Trump’s new vaccine czar”, Moncef Slaoui, at the helms of Research and Vaccines departments. It all peaked in 2010-2015 with some of the most sordid scandals people have ever ignored. Many will pay attention now, when things escalated to truly painful levels.
GlaxoSmithKline (GSK) can trace its roots back to a small apothecary in 18th Century London. Through multiple corporate mergers, GSK found its current form in 2001. It is well-known for its asthma inhalers like Advair and Breo. They have been constantly embroidered in scandals long before 2001. Suffice for now to mention a case of actual officially-recorded conspiracy, as reported by New York Times: In 1996 SmithKline Beecham was one of 15 drug companies that together agreed to pay more than $408 million to settle a class action lawsuit charging them with conspiring to fix prices they charged to thousands of independent pharmacies. In addition to contributing $30 million to the financial settlement, SmithKline agreed to supply the plaintiffs with a quantity of the generic version of its Tagamet ulcer medication worth $20 million.
We’re not going to review every GSK case in this investigation, just the truly spectacular and relevant ones from the more recent times, when the Research & Development and Vaccines departments were under Moncef Slaoui’s command. A new name to most, the Moroccan scientist has been dubbed by US media “Trump’s vaccine czar”, a few days back, when the US president made him co-chief of Operation Warp Speed, the coronavirus mass-vaccination campaign about to start in US.
GSK has began to break records with its penalties and settlements in 2006, when it promised “it would pay $3.1 billion to the U.S. Internal Revenue Service to resolve a 17-year dispute over the tax treatment of transactions between the company’s U.S. operation and the parent company. The settlement, the largest in IRS history, focused on the issue of transfer pricing—a method by which transnational corporations artificially reduce their tax liabilities”, as New York TImes reported
Anthony Faucci, Trump’s Vaccine Czar Moncef Slaoui and WHO collaborated on the H1N1 scamdemic of 2009, a rehearsal for the Plandemic of 2020. Their vaccine destroyed thousands of children
“As chief of vaccines at GSK, Slaoui oversaw the development of the disastrous Pandemrix vaccine for swine flu, a shot that was rushed to market without proper testing in the midst of a 2009 epidemic, during which public health officials were shrieking about enormous death tolls that never materialized, with some claiming the death toll would rival the 1918 influenza pandemic (sound familiar?).” RT reported recently in a quite superficial review of the H1N1 scandal of 2009. Let me give you the full picture.
A couple of recent articles by Prof Michel Chossudovsky for Global Research make a great review of the H1N1 2009 scamdemic, greatly completing my work. Chossudovsky practices practices the same old-school document-based style of journalism I was trained too, so I will copiously quote his work in this chapter, with regards and acknowledgements :
Based on incomplete and scanty data, the WHO Director General nonetheless predicted with authority that: “as many as 2 billion people could become infected over the next two years — nearly one-third of the world population.” (World Health Organization as reported by the Western media, July 2009).
It was a multibillion bonanza for Big Pharma supported by the WHO’s Director-General Margaret Chan,(wife of a high Chinese government official – Silview’s note).
In June 2009, Margaret Chan made the following statement:
Millions of doses of swine flu vaccine had been ordered by national governments from Big Pharma. Millions of vaccine doses were subsequently destroyed: a financial bonanza for Big Pharma, an expenditure crisis for national governments.(Global Research)
The media went immediately into high gear (without a shred of evidence). Fear and Uncertainty. Public opinion was deliberately misled
“Swine flu could strike up to 40 percent of Americans over the next two years and as many as several hundred thousand could die if a vaccine campaign and other measures aren’t successful.” (Official Statement of Obama Administration, Associated Press, 24 July 2009).
“The U.S. expects to have 160 million doses of swine flu vaccine available sometime in October”, (Associated Press, 23 July 2009)
Wealthier countries such as the U.S. and Britain will pay just under $10 per dose [of the H1N1 flu vaccine]. … Developing countries will pay a lower price.” [circa $40 billion for Big Pharma?] (Business Week, July 2009)
What was most governments’ vaccine of choice? Pandemrix, elaborated by Moncef Slaoui and GlaxoSmithKline
But the H1N1 pandemic never happened. There was no pandemic affecting 2 billion people…
The H1N1 scamdemic was endorsed in US by the CDC and the NIAID headed by Dr. Anthony Fauci. NIAID Director Fauci also endorsed Moncef Slaoui’s Pandemrix vaccine, which turned out to be a multi-billion dollar life-ruining scam:
The Pandemrix vaccine made by GlaxoSmithKline (GSK) was given to 6 million people in Britain and millions more across Europe during the 2009-10 swine flu pandemic, but was withdrawn when doctors noticed a rise in narcolepsy cases among those who received the jab.
Narcolepsy is a permanent condition that can cause people to fall asleep dozens of times a day, even when they are in mid-conversation. Some suffer from night terrors and a problem with muscular control called cataplexy that can lead them to collapse on the spot. (Guardian, September 25, 2015)
In UK, the result of the hasty approval process was an unsafe, ineffective shot that left over a thousand recipients permanently brain-damaged, some 80 percent of them children. Forty percent of NHS staffers were vaccinated under false pretenses, told the shot was safe and effective. The UK government was forced to pay out millions of pounds in compensation, as GSK had refused to supply the drug to governments until it was indemnified against lawsuits.
“The Pandemrix vaccine, made by GlaxoSmithKline, was given to high-risk groups, including children and those with asthma, diabetes and heart disease at the height of the 2009-10 swine flu pandemic. Across Europe, around 31 million people received the jab. The vaccine was made specifically to tackle pandemics and is very different to the normal seasonal flu vaccine which has not been linked to narcolepsy.
The condition is a rare but serious neurological disorder that affects about 31,000 people in Britain. The condition can cause massive sleep disruption. The worst hit are often young people who face enormous learning difficulties at school and university. The disorder can destroy self-esteem, and bullying is common. Adults can lose their jobs, their driving licences, and can have difficulties with relationships. Some narcoleptics have another condition called cataplexy, a total loss of muscle control.” – The Guardian 2013
In June, a 12-year-old boy was awarded £120,000 by a court that ruled he had been left severely disabled by narcolepsy caused by Pandemrix. The win ended a three-year battle with the government that argued his illness was not serious enough to warrant compensation.
The increased risk of narcolepsy after vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine indicates a causal association, consistent with findings from Finland. – British Medical Journal
A Department of Health spokesperson said: “Pandemrix was developed specifically for use in a flu pandemic when the number of lives lost and serious cases could have been enormous.” “The decision to recommend that children got this vaccine during the flu pandemic was based on evidence available at the time, along with the advice from the European Medicines Agency which approved its use.
The government is expected to receive a bill of approximately £60 million, with each of the 60 victims expected to receive about £1 million each.
Peter Todd, a lawyer who represented many of the claimants, told the Sunday Times: “There has never been a case like this before. The victims of this vaccine have an incurable and lifelong condition and will require extensive medication.”
Following the swine flu outbreak of 2009, about 60 million people, most of them children, received the vaccine.
It was subsequently revealed that the vaccine, Pandemrix, can cause narcolepsy and cataplexy in about one in 16,000 people, and many more are expected to come forward with the symptoms.
Across Europe, more than 800 children are so far known to have been made ill by the vaccine.
In a bitter irony, it was the UK Government (rather than GSK) that paid for the Vaccine Brain Damages in Children.
But the Brain Damage impacts documented in the UK and EU was but the tip of the iceberg.
Thousands of people got sick from the H1N1 Vaccine (reported and unreported cases).
GSK’s ArepanrixTD applied in Canada
The WHO’s H1N1 pandemic was declared in June 11, 2009. GSK was on contract to the Canadian government. The GSK’s ArepandrixTM vaccine was delivered to Canadian health authorities within less than four months.
Within four months?. Does that give them Time to Test????
Lots of people in Canada fell sick after receiving the H1N1 ArepanrixTD vaccine.
And that vaccine killed a little girl called Amina Abu, which then led to a ten year lawsuit against GSK.
A vaccine was rushed to market, and the five year old was among millions of Canadians to get the shot, amid widespread fears about the new pathogen.
Five days later, Amina’s older brother found her lying unconscious in the bathroom of the family’s east-end Toronto home. She was dead.
Her devastated parents came to blame the flu shot itself and sued the vaccine’s manufacturer, Glaxo Smith Kline (GSK), for $4.2 million. The little-noticed trial of that lawsuit drew toward a close on Tuesday, a rare judicial airing in Canada of a vaccine’s alleged side effects.
The parents’ lawyer, Jasmine Ghosn, alleged the preventive drug was brought out quickly and without proper testing during a chaotic flu season, as the federal government exerted “intense pressure” on Canadians to get immunized. (National Post, November 2019)
It took ten years for a judgment. The Family lost. GSK declined responsibility for her death. And the Canadian government reimbursed GSK’s legal expenses.
That lawsuit against GSK should be reopened. Canada’s government bears the burden of responsibility.
ArepanrixTD (2009) vs PandemrixTM (2009)
GSK has casually acknowledged that the ArepanrixTD which was used in Canada is “similar” to the GSK’s PandemrixTM applied in the UK and the EU, which led to brain damage in Children. It was subsequently withdrawn. But ArepandrixTD applied in Canada prevailed. An ArepandrixTD (2010) was subsequently released the following year (and compared to PandemrixTD (2009)
GSK acknowledges that PandemrixTD (2009) causes narcolepsy, which is categorized as “a chronic neurological disorder that affects the brain’s ability to control sleep-wake cycles.”
3. To date, how many people/children in Canada have reported developing narcolepsy after getting vaccinated with Arepanrix? What provinces do they reside in Canada?
GSK reports all cases of adverse events which the company is aware of in accordance with national and regional regulations. We respectfully defer to the Public Health Agency of Canada to address this question in more detail.
4. We read that there is currently a Canadian study sponsored by GSK to assess the risk of occurrence of narcolepsy following the administration of Arepanrix – Why did you sponsor that study? When will the results of that study be published?
We are currently supporting a study that is being conducted in Quebec where Arepanrix™ (H1N1) was used. Further research is needed to evaluate the potential association between GSK`s adjuvanted H1N1 pandemic flu vaccine and narcolepsy in a country where a similar vaccine to Pandemrix™ (H1N1) was used, and where a more robust assessment of the potential association could be conducted, using a design aimed at limiting the impact of biases. The preliminary results of this study are anticipated to be published by early 2014.
There was no investigation into who was behind this multibillion fraud. Several critics said that the H1N1 Pandemic was “Fake”
The Parliamentary Assembly of the Council of Europe (PACE), a human rights watchdog, is publicly investigating the WHO’s motives in declaring a pandemic. Indeed, the chairman of its influential health committee, epidemiologist Wolfgang Wodarg, has declared that the “false pandemic” is “one of the greatest medicine scandals of the century.” (Forbes, February 10, 2010)
The World Health Organization’s handling of the swine flu pandemic was deeply marred by secrecy and conflict of interest with drug companies, a top medical journal said Friday.
The British Medical Journal, or BMJ, found that WHO guidelines on the use of antiviral drugs were prepared by experts who had received consulting fees from the top two manufacturers of these drugs, Roche and GlaxoSmithKline, or GSK.
In apparent violation of its own rules, the WHO did not publicly disclose these conflicts when the guidelines were drawn up in 2004, according to the report, jointly authored by the London-based non-profit Bureau of Investigative Journalism.
The WHO’s advice led governments worldwide to stockpile vast quantities of antivirals, and its decision to declare a pandemic in June 2009 triggered the purchase of billions of dollars worth of hastily manufactured vaccines.
Much of these stocks have gone unused because the pandemic turned out to be far less lethal than some experts feared, fueling suspicion that Big Pharma exerted undue influence on WHO decisions.
The report also reveals that at least one expert on the secret, 16-member “emergency committee” formed last year to advise the WHO on whether and when to declare a pandemic received payment during 2009 from GSK.
Announcing that swine flu had become a global pandemic automatically triggered latent contracts for vaccine manufacture with half-a-dozen major pharmaceutical companies, including GSK. The WHO has refused to identify committee members, arguing that they must be shielded from industry pressure. “The WHO’s credibility has been badly damaged,” BMJ editor Fiona Godlee said in an editorial.
In 2010, after 8 years of legal battles, it’s sentenced to pay $96 to a whistle-blower. who exposed serious contamination problems at GlaxoSmithKline’s (GSK) pharmaceutical manufacturing operations.
“Cheryl Eckard’s payment is thought to be the biggest ever handed to a US whistleblower. It was awarded after an eight-year fight, which ended yesterday, when GSK agreed to pay the US government $750m to settle civil and criminal charges that it manufactured and sold adulterated drug products.” – The Guardian
One may argue the cases above may speak volumes about GSK, but this not Slaoui’s department, he probably had nothing to do with it. Yes, he may have not had his own hands in these particular scandal, but wait for it, as you will see, corruption is the norm at GSK, not something you can easily overlook, so unless he was forced to work for this corruption galore, he was an accomplice, at least ethically and morally, as all his colleagues are. We get to Slaoui’s departments shortly.
Year 2012 finds GSK experimenting on Argentina’s poorest babies. Moncef Slaoui’s people were going to Argentina’s most disparaged areas, tracking and tricking the poorest and most illiterate people to allow vaccine trials on their kids and babies. 14 deaths ensued. “The firm failed to get proper consent from the children’s parents before injecting Synflorix, one of its bestselling vaccines, according to a judge in Buenos Aires. GSK was also criticised for keeping inadequate records of the children’s ages, medical histories and previous jabs. Evidence from Argentina’s medical regulator said that, in a few cases, scientists working for GSK relied on permission from under-age parents or illiterate grandparents, The Times reported. GSK and two of the scientists who led the trial have been fined a total of one million pesos (£150,000). Jorge Yabkowsky, president of the Argentine Federation of Health Professionals, told The Times: “These are people who depend entirely on the state apparatus and who are most often illiterate.” – The Telegraph
“The Argentinian Federation of Health Professionals accuses drug maker GlaxoSmithKline of misleading participants and pressuring poor families into joining a trial for the Synflorix vaccine, which the company says protects against bacterial pneumonia and meningitis.”They recruited children in an irregular manner. … They did not do what they were supposed to. They did not inform. There were not independent witnesses. They pressured the mothers of poor children,” said Jorge Yabkowsky, the federation’s director.” – CNN
The trial, known as Compas, involved 15,000 Argentine babies and 9,000 in Colombia and Panama. It started five years before this scandal and continued long after, despite the fine, because that’s just “cost of business” on Planet Pharma.
But that was peanuts to GSK’s budget. considering same year, 2012, they paid a $3bn (£1.8bn) fine for misselling drugs in the US, “Largest Health Care Fraud Settlement in U.S. History” in the words of US Department of Justice. DOJ further stated: <<GSK agreed to plead guilty to a three-count criminal information, including two counts of introducing misbranded drugs, Paxil and Wellbutrin, into interstate commerce and one count of failing to report safety data about the drug Avandia to the Food and Drug Administration (FDA). Under the terms of the plea agreement, GSK will pay a total of $1 billion, including a criminal fine of $956,814,400 and forfeiture in the amount of $43,185,600. The criminal plea agreement also includes certain non-monetary compliance commitments and certifications by GSK’s U.S. president and board of directors. GSK’s guilty plea and sentence is not final until accepted by the U.S. District Court.
GSK will also pay $2 billion to resolve its civil liabilities with the federal government under the False Claims Act, as well as the states. The civil settlement resolves claims relating to Paxil, Wellbutrin and Avandia, as well as additional drugs, and also resolves pricing fraud allegations.
“Today’s multi-billion dollar settlement is unprecedented in both size and scope. It underscores the Administration’s firm commitment to protecting the American people and holding accountable those who commit health care fraud,” said James M. Cole, Deputy Attorney General. “At every level, we are determined to stop practices that jeopardize patients’ health, harm taxpayers, and violate the public trust – and this historic action is a clear warning to any company that chooses to break the law.”>>
Rewind that: A Deputy Attorney General said in a DOJ press release that GSK “jeopardized patients’ health, harmed taxpayers, and violated the public trust“.
You think that’s bad? Reading further in the DOJ press release we find out that Bill Corr, Deputy Secretary of the Department of Health and Human Services (HHS) really called it out:
“cheaters who thought they could make an easy profit at the expense of public safety, taxpayers, and the millions of Americans who depend on programs like Medicare and Medicaid”
“GSK, one of the world’s largest healthcare and pharmaceuticals companies, admitted to promoting antidepressants Paxil and Wellbutrin for unapproved uses, including treatment of children and adolescents. The illegal practice is known as off-label marketing. The company also conceded charges that it held back data and made unsupported safety claims over its diabetes drug Avandia. It agreed to resolve civil liability for promoting asthma drug Advair and two lesser-known drugs for unapproved uses.
In addition, GSK has been found guilty of paying kickbacks to doctors.” – BBC
“The sales force bribed physicians to prescribe GSK products using every imaginable form of high-priced entertainment, from Hawaiian vacations [and] paying doctors millions of dollars to go on speaking tours, to tickets to Madonna concerts”
The public hardly got scandalized and mostly by the bribes, but the most serious crime is the one committed by Slaoui’s department, Forbes being one of the very few media that nailed this: “Keeping safety data secret: Federal investigators say that between 2001 and 2007, GlaxoSmithKline failed to disclose safety data from certain studies of Avandia to the Food and Drug Administration. This is, ethically, perhaps the most serious of the charges. Glaxo’s handling of the Avandia matter was fraught with bad disclosure bordering on deceit. During that time period, Avandia became the best-selling diabetes drug in the world. Now it not only bears warnings that it might cause heart attacks, its use has been so restricted that the drug has nearly vanished off Glaxo’s ledgers. To the extent that Glaxo kept Avandia’s heart risk from being recognized, that means that patients were exposed to added risks. For this, Glaxo is paying a fine of $243 million.”
As part of the settlement, GSK agreed to be monitored by US government officials for five years. Only to see the company embroiled in another humongous scandal within a year, as they re-based their corruption in China.
The 2013 scandal “started with sex tapes of the company’s China head, Mark Reilly and his Chinese girlfriend at a Shanghai department, which were sent to several senior executives of the company. The company’s investigations into the sex tapes made the paid investigator Peter Humphrey and his wife Yu Yingzeng in jail in China due to their breach of privacy law. With the bribery scandal made public by the Chinese police since June 2013, GSK had to admit its pervasive corruption in China. After tried in Changsha in September 2014, the company apologized to the Chinese people, and paid one of the biggest fines in Chinese history worth ¥3bn (£300m; €350m; $490m).4 executives of the company, including Mark Reilly, the only foreign citizens involved, were sentenced to jail. Reilly was deported from China as well. The sequent US Securities and Exchange Commission investigation was settled by GSK with a $20 million civil penalty in 2016, yet the UK Serious Fraud Office failed to finish the expensive investigation which was officially ended in 2019.” Wikipedia
The corruption at GSK was multi-levelled and ubiquitous, it wasn’t just bribes for sales, that’s why the scandal needed about 5 years to find closure, more or less. GSK board received an email in January 2013 where how China’s branch committed fraud in its operations was detailedly described in 5,200 words. The email was well written in English. The email said that GSK China disguised tourist travel in the disguise of international academic meetings. The company paid for the airline tickets and hotel rooms for such meetings to bribe Chinese medical professionals. The email continued by accusing GSK China of falsifying its books and records to illegally market drugs in China. The whistleblower made examples by the drug Lamictal, which was approved in China only for treating epilepsy, but was marketed as a drug for bipolar disorder aggressively. The drug killed a patient due to false marketing, but GSK chose to pay around 9,000 US dollars to silence the patient.
From 2013’s ScienceMag we find out that “accusations of data fabrication at GlaxoSmithKline’s China research site are quite real. That’s what we get from the latest developments in the case, as reported by BioCentury, Pharmalot, and the news section at Nature Medicine. Jingwu Zang, lead author on the disputed paper and former head of the Shanghai research site, has been dismissed from the company. Other employees are on administrative leave while an investigation proceeds, and GSK has said it has begun the process of retracting the paper itself. As for what’s wrong with the paper in question, BioCentury Extra has this:
GSK said data in a paper published in January 2010 in Nature Medicine on the role of interleukin-7 (IL-7) in autoimmune disease characterized data as the results of experiments conducted with blood cells of multiple sclerosis (MS) patients “when, in fact, the data reported were either the results of experiments conducted at R&D China with normal (healthy donor) samples or cannot be documented at all, suggesting that they well may have been fabricated.”
The pharmaceutical giant’s head of global research & development at the time, Moncef Slaoui, received a total remuneration package of $8.4m for his work in 2013, up from $6.6m in 2012.“
Moncef Slaoui was very close to the Chinese GSK division because, as I pointed out in my previous article, in 2007, he announced plans to establish a neurosciences research group in Shanghai that would employ a thousand scientists and cost $100 million. This was one of his biggest projects at GSK, so much of his time and energy were spent through at the China branch. Slaoui’s megalomaniac plans failed miserably and ceased operations in August 2017, which is the most probable cause of his departure from GSK same year.
The following year, 2014, “the pay packets of finance boss Simon Dingemans and vaccines head Moncef Slaoui also took a hit last year. Mr Dingemans received £1.9m, down from £3.3m the year before. Dr Slaoui got $4.3m (£2.8m), compared with his $8.4m remuneration in 2013.”, reported The Telegraph. GSK had to recover from one of the biggest fines in history!
“China has fined UK pharmaceuticals firm GlaxoSmithKline $490m (£297m) after a court found it guilty of bribery” – BBC, 2014
<<The record penalty follows allegations the drug giant paid out bribes to doctors and hospitals in order to have their products promoted. The court gave GSK’s former head of Chinese operations, Mark Reilly, a suspended three-year prison sentence and he is set to be deported. Other GSK executives have also been given suspended jail sentences.
Chinese authorities first announced they were investigating GSK in July last year (2013 – the year Slaoui was cashing big bonuses – Silview’s note), in what has become the biggest corruption scandal to hit a foreign firm in years. The company was accused of having made an estimated $150m in illegal profits.
GSK said it had “published a statement of apology to the Chinese government and its people”.
“Reaching a conclusion in the investigation of our Chinese business is important, but this has been a deeply disappointing matter for GSK,” said chief executive Sir Andrew Witty in a statement. “We have and will continue to learn from this. GSK has been in China for close to a hundred years and we remain fully committed to the country and its people,” he said. “We will also continue to invest directly in the country to support the government’s health care reform agenda and long-term plans for economic growth.”
Mick Cooper, analyst at Edison Investment Research in London, said: “GlaxoSmithKline will hope that this will draw a line under events in China, but it will take time for its Chinese commercial operations to recover.>> – BBC, 2014
US authorities then investigated whether GSK breached the Foreign Corrupt Practices Act, while the UK’s Serious Fraud Office (SFO) launched a formal criminal investigation into its overseas practices in May. “The SFO criminal investigation into the commercial practices of GlaxoSmithKline and its subsidiaries continues,” a spokeswoman at the SFO told Reuters in 2014.
Funnily, this event is what changed Slaoui’s course of life and made him a candidate for Trump’s Operation Warp speed. Because the scandal shook GSK’s hierarchies, with Slaoui moving from R&D to heading the vaccines branch.
The US Centres for Disease Control and Prevention has begun discussions with ministry of health officials in Nigeria about conducting a phase 1 safety study of the vaccine among healthy adults.
The Oxford study involved 60 healthy volunteers, while those in the Gambia and Mali will each involve 40.
Hill said: “The tragic events unfolding in Africa demand an urgent response. In recent years, similar investigational vaccines have safely immunised infants and adults against a range of diseases including malaria, HIV and Hepatitis C. We, and all our partners on this project, are optimistic that this candidate vaccine may prove useful against Ebola.”
The experimental vaccine is against the Zaire species of Ebola, which is the one circulating in west Africa and for which there is no cure. The vaccine was designed by Nancy J Sullivan, the head of the biodefence research section in NIAID’s Vaccine Research Centre (part of NIH), in collaboration with researchers at the Swiss-Italian biotech firm Okairos, acquired by GSK last May for €250m (£150m), The Guardian reported in 2014
Same Adrian Hill we find later co-authoring the AstraZeneca Covid vaccine under his own company Vaccitech.
Two scientists behind Oxford University’s coronavirus vaccine could pocket a hefty sum of money if the jab proves successful, it emerged today.
Several private investors, including the controversial Chinese firm Huawei, are also poised to profit if the vaccine — called AZD1222 — goes to market.
Oxford professors Sarah Gilbert and Adrian Hill co-founded Vaccitech in 2016. The start-up created the experimental jab — still in human trials — alongside experts at the university’s Jenner Institute.
Company House records show the experts own roughly 10 per cent of the company, which was valued at £65.8million last year before the pandemic hit. It means the pair will be entitled to their share of revenue if the Covid-19 jab makes it to market and is sold for profit.
For comparison, influenza vaccines make around £4billion profit for pharmaceutical companies every year, globally.
Several Chinese investors, including a Dutch arm of Huawei, also own shares in the company listed as Vaccitech’s biggest funder.
It means Huawei — which has been blacklisted by the UK and US amid fears it could use its tech to spy on the West — may also gain handsomely if the Covid-19 jab is proven to work and be safe over the next few months.
Eyebrows will also be raised about the fact Huawei, which was banned from operating the UK’s 5G mobile network last month amid spying fears – is in line to profit from the vaccine if it is proven to be successful.
The telecoms giant is a shareholder in Oxford Sciences Innovation (OSI), a venture capital company that seeks investment to fund new technologies and research projects.
Public records show Huawei Technologies Cooeperatief, a Dutch arm of the maligned firm, bought 4.1million shares in OSI last July, roughly a 0.7 per cent stake, the Financial Times reports.
OSI has raised £600m in four years from 70 shareholders, including Temasek Holdings, which is owned by the Singapore government, GV, an investment firm owned by Google, the Chinese drugmaker Fosun Pharma, and the Wellcome Trust, a research charity based in London.
OSI has a breadth of startup tech companies under its portfolio including Oxford Nanoimaging, a microscope manufacturer, Oxford Flow, which designs pressure control equipment for the oil and gas industry, and vaccine maker Vaccitech.
As Vaccitech’s biggest investor, OSI owns a 46 per cent stake in the company. The UK Government has also invested about £5million in the jab maker at the start of the pandemic.
Last month, the Government banned mobile providers from buying new Huawei 5G equipment amid fears the Chinese firm would use its tech to spy on the West.
UK companies using Huawei kit must strip it out of their networks by 2027, in a move that will slowdown the rollout of 5G in the UK by at least a year.
The move brought the UK closer in line with the US, where Huawei has been banished from selling even its smartphones to Americans.
Washington claims the firm poses a national security threat because it takes orders from China’s Communist Party.
The Oxford vaccine is one of the frontrunners to become the first jab against Covid-19.
But the researchers behind the trials have had to move their studies abroad to South Africa and Brazil — where Covid-19 is still rife — to speed up the so-called efficacy trials.
There has been growing concern not enough people are catching the virus in the public in the UK anymore, which makes it hard to test whether the jab actually protects people from catching it. – Daily Mail
Why do they always “speed up” trials in the poorest areas of Africa and South America? See below.
GlaxoSmithKline bribery scandal led to 13-fold increase in China whistleblower reports –The Telegraph 2015
Drug maker received 652 reports of misconduct in China in 2014, up from 48 in the previous year
Did a any of that slow the corruption machine down, did they ever stop? On 2014-15 they were also investigating other allegations that GSK paid incentives to secure sales of its products in countries including Romania, Syria, Poland, Iraq, Jordan, UAE and Lebanon.
GlaxoSmithKline PLC is investigating allegations of bribery by employees in the Middle East, according to emails reviewed by The Wall Street Journal, opening a new front for the company as it manages a separate corruption probe in China.
A person familiar with Glaxo’s Mideast operations emailed the U.K. drug company late last year and earlier this year to report what the person said were corrupt practices in Iraq, including continuing issues and alleged misconduct dating from last year and 2012″
The Guardian, April 7th 2014: “GSK looking into claims that it hired 16 Iraqi government doctors and pharmacists to improperly boost its sales Details of the allegations, which are said to have originated in 2012 but continue to this day, were sent to company executives by a whistleblower, according to the Wall Street Journal. The emails claim the alleged malpractice breaches the UK’s Bribery Act and the US Foreign Corrupt Practices Act, which ban bribery of foreign officials.”
The Guardian, April 14th 2014 “GSK acknowledged the Polish allegations dating from 2010 after an investigation by the BBC’s Panorama programme GlaxoSmithKline, the British drug company embroiled in bribery scandals in China and Iraq, has been accused of bribing doctors in Poland in the latest corruption furore to hit the business. The company, which has made a series of public promises to “root out corruption wherever it exists” following allegations that it bribed doctors with £320m worth of cash and sexual favours in China, admitted on Monday that a GSK employee was disciplined in relation to the Polish allegations. GSK, which has repeatedly trumpeted its “zero tolerance” corruption policy as it battles to salvage its corporate reputation, only acknowledged the Polish allegations – which date back to 2010-12 – after an investigation by the BBC’s Panorama programme.”
The Guardian, April 16th 2014: “GlaxoSmithKline says it is investigating bribery claims in Jordan and Lebanon Allegations say GSK sales representatives bribed doctors by issuing free samples that they were then allowed to sell on”
Reuters, August 11th 2014: “Exclusive: GlaxoSmithKline faces fresh drug bribery claims in Syria Reuters last month reported allegations of corruption in GSK’s Syrian consumer business, which sells products including toothpaste and painkillers. The consumer operation was closed in 2012 due to the worsening civil war in the country. The Syrian prescription pharmaceuticals business remains operational, however, and GSK said it was committed to supplying safe and effective drugs and vaccines to patients in need. The new corruption claims involve alleged bribes paid to boost sales of various medicines, including ones to treat cancer and to prevent blood clots.”
Reuters, July 25th, 2015: “Exclusive: GSK faces new corruption allegations, this time in Romania The latest allegations say GSK paid Romanian doctors hundreds, and in one cases thousands, of euros between 2009 and 2012 for prescribing its medicines, including prostate treatments Avodart and Duodart and Parkinson’s disease drug Requip.
According to the email, the doctors were notionally paid for speaking engagements, but in three out of six cases, including the most highly paid one, they did not give any speech. The other three medics gave only one speech each, despite receiving multiple payments. GSK also provided doctors with many international trips and made payments to them under the guise of participation in advisory boards, the email said.”
Securities and Exchange Commission, September 30, 2016 (PDF): “GlaxoSmithKline plc (“GSK”) has agreed to pay $20 million to settle charges that it violated the Foreign Corrupt Practices Act (FCPA) when its China-based subsidiaries engaged in pay-toprescribe schemes to increase sales. An SEC investigation found that the schemes spanned a period of years and involved the transfer of money, gifts, and other things of value to health care professionals, which led to millions of dollars in increased sales of GSK pharmaceutical products to China’s state health institutions. The participants included certain complicit sales and marketing managers within GSK’s Chinabased subsidiaries. GSK failed to devise and maintain a sufficient system of internal accounting controls and lacked an effective anti-corruption compliance program to detect and prevent these schemes. As a result, the improper payments were not accurately reflected in GSK’s books and records. The SEC’s order finds that GSK violated the FCPA’s internal controls and books-and-records provisions. GSK consented to the order without admitting or denying the findings, and agreed to pay a $20 million civil penalty. GSK also agreed to provide status reports to the SEC for the next two years on its remediation and implementation of anti-corruption compliance measures.”
Moncef Slaoui leaves GSK in 2017, after having brought the company on the brink of disaster, together with the Chinese division. Together with GSK’s #1 through this period, the disgraced CEO Andrew Witty, one of the darkest figures in medicine’s history, Moncef Slaoui moves to become a Pharma investor aboard Medicxi Capital, a biotechnology venture capital firm in the Philadelphia, Pennsylvania area. The rest is business as usual.
To be continued
LATER UPDATE 2, For the giggles: This is how Dork Suckerborg of Fakebook fame is doing damage control for this investigation
And this is how I do Suckerborg control. Guess what? Five minutes after I posted the thing below, Suckerborg re-instated the original post and deleted this from the group, Of course I posted it back in the comments of the original. Take your time to enjoy the multilevel beauty here, then tell me about 3d chess…
To be continued? Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
I’m reporting from captivity in Agadir, a Moroccan city which I’ve just found out it’s the birth-place of Moncef Slaoui, the newly appointed head of “Operation Warp Speed” , Trump’s mass-vaccination campaign. And the that’s the least disturbing thing I have to tell you. I probably need protection now, I’m warned, authorities here are not big fans of free speech, people have been arrested for much less. But this isn’t much of a life anyway; all worth it if you spread this knowledge like fire. May the public eye be my protection, if any.
US President Donald Trump selected Moroccan immunology expert Moncef Slaoui to be the head of his administration’s COVID-19 vaccine development team, working on “Operation Warp Speed.”
The Moroccan expert, 60, will serve as the US government’s “therapeutics czar” to help coordinate the development of vaccines and treatments. The role is shared between the US Department of Health and Human Services and the Department of Defense.
Slaoui will be assisted by Army Gen. Gustave Perna, the commander of United States Army Materiel Command.
Slaoui earned a Ph.D. in molecular biology and immunology from the Free University of Brussels, Belgium, and completed his postdoctoral studies at Harvard Medical School and Tufts University School of Medicine, Boston.
He was the former head of the vaccines division at GlaxoSmithKline (GSK), where he oversaw the development of various vaccines: Rotarix, Synflorix, and Cervarix. In 2007, he announced plans to establish a neurosciences research group in Shanghai that would employ a thousand scientists and cost $100 million; it failed miserably and ceased operations in August 2017.
In 2008, Slaoui led the $720 million acquisition of Sirtris Pharmaceuticals, which folded in 2013. In 2012, he oversaw GSK’s purchase of Human Genome Sciences for over $3 billion. In 2015 he won European approval for the world’s first malaria vaccine (Mosquirix).
When he retired from the drugmaker in 2017, GSK was still working on the vaccine for Ebola.
GSK is now working on a COVID-19 vaccine with Sanofi, the French multinational pharma giant.
“Not long after leaving GSK, the enthusiastic and outgoing Slaoui started joining biotech boards, with welcomes at SutroVax, mRNA player Moderna as well as the public outfit Intellia $NTLA, one of a handful of CRISPR/Ca9 gene editing startups dominating the field. Then, a little over a month ago, he dropped off the Intellia crew, citing a conflict but not explaining it.” – Endpoints
But his biggest business move was becoming a partner at Medicxi Capital, a biotechnology venture capital firm in the Philadelphia, Pennsylvania area.
Medicxi has built a highly experienced team and, through the scientific advisory boards (SABs) of each of its funds, has access to some of the most respected names in the pharma industry. As well as Medicxi’s senior team, now including Dr Slaoui, external members and observers on the SABs to Medicxi’s funds included (2017):
Dr Vasant (Vas) Narasimhan, Global Head of Drug Development, Chief Medical Officer and Chief Executive Officer Elect
Dr Evan Beckman, Global Head of Translational Medicine at NIBR
Nigel Sheail, Head of Business Development and Licensing
From Verily Life Sciences:
Dr Andy Conrad, Chief Executive Officer
Dr Robert Califf, Advisor and former US FDA Commissioner
Dr Patrick Vallance President, R&D
Dr Paul-Peter Tak Senior Vice President R&D Pipeline, Global Development Leader and Chief Immunology Officer
From Johnson & Johnson:
Dr. Paul Stoffels, Executive Vice President, Chief Scientific Officer
Dr. Bill Hait, Global Head, Janssen Research & Development
Dr Patrick Verheyen Global Head, Janssen Business Development
Michèle Ollier, co-founder and Partner at Medicxi, said: “Moncef has made a tremendous contribution through his role on our SABs and we look forward to his continued energetic and insightful contribution as a Partner at Medicxi. Our SAB meetings are challenging, insightful and inspiring, and contribute hugely to how we steer and advise our portfolio companies.”
Medicxi is based in London, Geneva and Jersey. The Company’s mission is to invest across the full healthcare continuum. Medicxi was established by the former Index Ventures life sciences team. Medicxi manages the legacy life science portfolio of Index Ventures as well as the new funds launched as Medicxi, Medicxi Ventures 1 (MV1) and Medicxi Growth 1 (MG1) focusing on early-stage and late-stage investments in life sciences.
GSK, Johnson & Johnson and Novartis, three of the world’s largest pharmaceutical companies back Medicxi along with Verily, an Alphabet company. These companies, whilst participating in the SABs of the funds, do not receive any preferential rights to the portfolio companies.
Medicxi’s team has been investing in life sciences for over 20 years and has backed many successful companies, including Genmab (NASDAQ Copenhagen: GEN), PanGenetics (sold to AbbVie), Molecular Partners (SWX: MOLN), XO1 (sold to Janssen) Egalet (NASDAQ: EGLT), Minerva Neurosciences (NASDAQ: NERV) and Versartis (NASDAQ: VSAR).
Since 2017, Slaoui has been also sitting on the board of Moderna, a biotechnology company also pursuing a COVID-19 vaccine, based in Cambridge, Massachusetts.
The other problem, because they always come in pairs: Trump awarded Moderna almost $0.5Billion from public money a few days before nominating Slaoui. CNN reported on May 18th:
“Valera’s efforts (Moderna subsidiary) have resulted in the demonstration of preclinical efficacy of Moderna’s mRNA-based vaccines in multiple viral disease models, Moderna said.
In the partnership with the Gates Foundation, Valera will apply its mRNA vaccine platform as well as Moderna’s drug platform Messenger RNA Therapeutics™. Designed to produces human proteins, antibodies, and entirely novel protein constructs inside patient cells, the therapeutics are secreted or active intracellularly.” – Genetic Engineering & Biotechnology News
What, you think that’s bad? What if I told you this is the last one in a very long series of collaborations between the two?
Why is no one talking about this chapter of Moncef Slaoui’s career? Well, I am:
I find most relevant this transhumanist project Slaoui worked on with Google from 2016, as reported by Bloomberg:
<<The recent partnership between GlaxoSmithKline (GSK) and Alphabet (Google) further opens the door for development in the biotechnology industry’s experimental “bioelectronics” segment. Chairman of Vaccines at GlaxoSmithKline Dr. Moncef Slaoui thinks the partnership could create an entirely new industry. “I think this is a whole new industry as big as the pharmaceutical industry … there’s a whole new world that we’re opening here which is dealing with electrical signals to connect with our biology and changes functioning,” Slaoui told CNBC’s Meg Tirrell on “Squawk Box” Monday morning. Calling Alphabet’s Verily Life Services a “really exciting partner,” Slaoui says GlaxoSmithKline shares “a very common vision of integrating electronics and big data analytics and technologies with medicines and biology.” “They bring to us the engineering capabilities, the electronics, the low power technologies and the wireless technologies that are critical to miniaturize these devices, power them and extract information from them,” Slaoui noted.>>
“GSK has been interested in this field for years, and in 2013 announced a $1 million prize for innovative bioelectronics research. In a press statement, GSK’s Moncef Slaoui said: “Many of the processes of the human body are controlled by electrical signals firing between the nervous system and the body’s organs, which may become distorted in many chronic diseases.” He said bioelectronic seeks to “correct the irregular [electrical] patterns found in disease states, using miniaturized devices attached to individual nerves.” – The Verge
And having in mind the technological terror, the transhumanist/eugenicist obsessions brought by the coronavirus policy-makers today, one quote from the same source above hits home. This whole business falls right in the arms of anyone associating the coronavirus pandemic with human microchipping. Slaoui cited animal models as the indicator that bioelectronics can treat chronic diseases with a number of different devices.
The devices themselves are very small, about “the size of a rice grain”, and can “either stimulate or black the electric signals that our brains sense through our nerves to control the functioning of our organs… The limitations are around power as power requires energy and energy means heat and heat doesn’t go well with biology.
It gets weirder
Slaoui rejected reports in late March of his involvement with a US government task force for COVID-19 vaccine development and denied as recently as May 11 any intention to work with the Trump administration. WHY?? Morocco World News reported in March 31st: “The doctor said he has no working arrangements with the US government in a statement to Moroccan French-language newspaper L’Economiste. Several local news outlets claimed that the former chairman of pharmaceutical giant GlaxoSmithKline (GSK) is part of a task force that is researching a vaccine to clamp down on the spread of the virus. The international expert is currently a member of the board of directors of American biotechnology company Moderna. Slaoui explained that he is part of the company’s research and development committee. The committee has received support from federal organizations to help fund the development of a COVID-19 vaccine. “
White House senior adviser Jared Kushner, the son-in-law of President Trump, was among the officials who interviewed Slaoui for the role.
Jared Kushner went there. Jared Kushner personally picked America’s new “Vaccine Czar” Moncef Slaoui precisely one year after the meeting. Jared Kushner is a Zionist. Jared Kushner is Trump’s son law.
To avoid a conflict of interest, Slaoui resigned from the board of the Massachusetts-based biotech firm Moderna, which had been developing a vaccine for the coronavirus. He stepped down but he didn’t give up his stakes in Moderna, as the Daily Beast reports:
“Slaoui’s ownership of 156,000 Moderna stock options, disclosed in required federal financial filings, sparked concerns about a conflict of interest. Democratic Massachusetts Senator Elizabeth Warren called Slaoui out over the matter on Twitter: “It is a huge conflict of interest for the White House’s new vaccine czar to own $10 million of stock in a company receiving government funding to develop a COVID-19 vaccine. Dr. Slaoui should divest immediately.” The company’s shares skyrocketed last month after news broke of the $483 million in federal funding to work on a coronavirus vaccine. Slaoui could not immediately be reached for comment on the matter.”
Slaoui also sits on the boards of SutroVax, the Biotechnology Innovation Organization, the International AIDS Vaccine Initiative, and the PhRMA Foundation
The Moroccan expert’s main contenders for the position of chief advisor at “Operation Warp Speed” were Algeria’s Elias Zerhouni and US’ Arthur Levinson.
Zerhouni, born in 1951, is an Algerian scientist, radiologist, and biomedical engineer. The expert has held several important positions in a number of institutions, ranging from medical schools to pharmaceutical companies and government task forces.
In 2009, under the Obama administration, Zerhouni served as the first science envoy in the US and worked towards fostering scientific and technological collaboration with other countries.
Between 2011 and 2018, as a final stage in his career, Zerhouni was the President for Global Research and Development at, well, Sanofi.
The third main candidate in the race for Trump’s COVID-19 operation, Arthur Levinson, is an American businessman specialized in biotechnology.
Levinson has served as senior advisor for several companies and institutions, including Swiss healthcare multinational Hoffmann-La Roche, Amyris Biotechnologies, the Memorial Sloan Kettering Cancer Center, the California Institute for Quantitative Biosciences, and Princeton University.
The American businessman is currently the chairman of tech giant Apple and CEO of biotechnology company Calico.
“We will get to [vaccines] eventually, but we’re not there yet. If we want to lift the lockdowns, we need to fully respect them first”
Outlook on the pandemic
During an interview on April 12, Slaoui said he expects life to begin its return to normal at the beginning of 2021 after global leaders rein in the pandemic, adding that he considers his prediction “optimistic.”
He is confident “that due to the high number of COVID-19 cases, clinical studies will reach results quickly.” He believes that “by the end of May or by early June, we will know if some of these drugs work.”
“I am very optimistic that we’ll have several vaccines for COVID-19. However, the problem is not having a vaccine. The problem is producing enough to protect eight billion people,” he continued.
Which is weird, because US Government has just announced same day spending $138mil. to turbo-boost vaccine production, and I’ve published a massive investigation piece on that.
In another interview with Moroccan television channel 2M on April 13, Slaoui forecast that the COVID-19 pandemic will heavily scar the global population.
“I believe that by 2021 our reality will not be completely back to normal but it will be improved,” he argued.
Moncef Slaoui said if the virus continues to spread, there will be no way to control it other than to create a vaccine and administer it on a massive scale.
“We will get to [vaccines] eventually, but we’re not there yet. If we want to lift the lockdowns, we need to fully respect them first,” he explained.
He said countries can phase out lockdowns when there is a proven COVID-19 treatment.
Slaoui acknowledged that there are now hundreds of clinical studies underway in many countries.
He expressed optimism that due to the increasing number of COVID-19 cases, clinical studies will achieve preliminary results quickly. “I believe that by the end of May or by early June, we will know if some of these drugs work.”
Government watchdog Public Citizen on Thursday “condemned the Trump administration’s reported appointment of a former pharmaceutical executive to the White House’s task force aimed at swiftly developing a Covid-19 vaccine as another example of the White House putting management of the pandemic in the hands of private industry. “
“If the Trump administration approaches vaccine development as it has Covid-19 prevention, testing, and treatment, the world may be in for years of more extraordinary pain,” Maybarduk added. “The dangers of global vaccine rationing are profound. No one corporation has the capacity to deliver a vaccine to all the world’s people.”
In March, Trump’s FDA came under fire for awarding monopoly status to Gilead Sciences for Remdesivir, a drug it was developing for Covid-19 treatment. The company backed off its claim after a pressure campaign led by Public Citizen.
“The U.S. government must commit to sharing clinical trial data, patents, and know-how among manufacturers and with the world, to quickly achieve the mountainous scale of production that humanity needs,” the group said.
Everything makes even more sense if you also read the first part of this series of articles dedicated to the covid mafia and Operation Warp Speed
To be continued? Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them